Sonoma Pharmaceuticals, Inc. SNOA
1.11 USD +0.04 (+3.74%)
At closeNov 6, 2026, 7:53 PM EST
1.12 +0.01 +0.78%
After hours · Nov 6, 7:53 PM ET
1.08 Day range 1.15
1.01 52-week range 3.80
- YTD
- -69.51%
- 1 year
- -69.59%
Revenue & Expenses
Latest period ending Mar 31, 2026 · select a line to chart its full history
Income statement
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| 19.53M | 14.29M | 12.73M | 13.27M | 12.63M | |
| 7.42M | 5.46M | 4.75M | 4.48M | 3.99M | |
| -2.46M | -3.71M | -4.70M | -4.57M | -5.74M | |
| -3.17M | -3.46M | -4.83M | -5.15M | -5.09M | |
| -1.89 | -2.79 | -10.63 | -30.40 | -38.40 |
Balance sheet
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| 2.40M | 5.37M | 3.13M | 3.82M | 7.40M | |
| 13.96M | 13.69M | 14.74M | 16.23M | 18.84M | |
| 10.87M | 9.28M | 8.60M | 8.25M | 10.15M | |
| 842.00K | 305.00K | 608.00K | 849.00K | 1.37M | |
| 3.10M | 4.41M | 6.14M | 7.98M | 8.70M |
Cash flow
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| -3.93M | -88.00K | -2.40M | -6.15M | -4.25M | |
| -192.00K | -80.00K | -2.00K | -258.00K | -99.00K | |
| 477.00K | 3.03M | 1.68M | 2.49M | 7.40M | |
| -192.00K | -80.00K | -2.00K | -269.00K | -137.00K | |
| -2.98M | 2.25M | -692.00K | -3.58M | 3.18M |